Total Achievable Market = Global Alzheimer’s Disease Pharmaceutical Industry
2020: $5.9 Billion, Compound Annual Growth Rate 10.5%
2023: $13.3 Billion
2030: $50 Billion
Serviceable Achievable Market = Global Alzheimer’s Population
2020: 50 Million patients
2023: 57 Million patients
2030: 70 Million patients
· 1 in 10 persons > 65 years old, 1 in 3 persons > 85 years old
· 14% increase in cases annually
Our market survey was segmented into 2 target audiences.
First, we polled 542 Adult Neurologists and Geriatric Medicine Physicians from the following Academic Centers and Community Hospitals.
Second, we interviewed executives from the following pharmaceutical companies.
Results validate our company’s purpose and targets.
Of the 119 responses received, the majority of doctors feel that the top 3 unmet needs in Alzheimer’s treatment are targeted drug delivery, drug bioavailability, and optimizing drug release.
Almost all predict that the number of Alzheimer’s patients in their practice will increase over the next decade.
And 92% of these physicians see promise in nano-ADEPT.